|
Match
|
Document |
Document Title |
|
|
7601201 |
Method of removing carbon monoxide from an oxygen carrier and apparatus for removing carbon monoxide
A method of removing carbon monoxide from an oxygen carrier including setting a carbon monoxide bonded oxygen carrier solution across a separation membrane from an oxygen-dissolved solution; and...
|
|
|
7592134 |
Viral reduction method for plasma using a leukocyte-reduction filter and two virus-reduction filters of decreasing pore diameters
The present invention relates to a plasma product or a serum product with an extremely low risk of viral contamination and a method for producing the same. Before treating plasma or serum to be...
|
|
|
7572465 |
Isolated material having an anti-organotrophic effect
A material having the ability to reduce organ mass has been isolated by collecting ovarian venous blood from a female mammal; preparing ovarian venous plasma from the blood; and at least partially...
|
|
|
7510732 |
Analgesic and anti-inflammatory composition
The present invention discloses a composition that contains (1) an effective amount of an analgesically and/or anti-inflammatory active fraction separated from a mixture of plasma and/or serum, and...
|
|
|
7482162 |
Determination of vitamin D metabolite and displacement from plasma or serum binding proteins
We disclose methods for measuring vitamin D metabolite in plasma or serum samples. The methods comprise a step of adding to the plasma or serum samples a non-competitive displacement agent...
|
|
|
7442308 |
Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process
A process for removing viruses in fibrinogen solutions and fibrinogen obtained thereof wherein the process starts with an adjusted purified fibrinogen solution, the adjusted purified solution is...
|
|
|
7351422 |
Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same
Proposed is a novel soluble trauma-healing and hemostatic cellulose fiber capable of absorbing and readily dissolving hemorrhaging trauma loci when applied thereto and of promoting the hemostatic...
|
|
|
7348411 |
Process for manufacturing fibrin membranes and fibrin membranes obtained according to this process
A process for manufacturing a fibrin membrane from blood plasma that was partially depleted and subjected to coagulation by adding a solution of a physiological coagulating agent, leaving the...
|
|
|
7208179 |
Methods for treating disease and forming a supplemented fibrin matrix
This invention provides supplemented and unsupplemented tissue sealants as well as methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one...
|
|
|
7182962 |
Immunostimulator for animals and humans, and method of preventing animal and human infectious diseases and cancer
The goal of the present invention is to provide substances to prevent diseases by activating inherently possessed functions, for cultured fishes and shellfishes and livestock with tendency of...
|
|
|
7182744 |
Method and apparatus for aneurismal treatment
An irritant or polymer is dispensed to the inner surface area of an aneurysm to exert a contractile force on the inner surface area of the aneurysm, thereby shrinking the aneurysm. As a result, the...
|
|
|
7169547 |
High concentration white blood cells as a therapeutic product
A therapeutic product formed from a high concentration of white blood cells having a high degree of cell viability. The white blood cells are sequestered from their normal population presence in...
|
|
|
7125569 |
Removal of plasmin(ogen) from protein solutions
A method for specifically removing or isolating plasmin(ogen) or plasmin in presence of fibrinogen from a mixture containing plasmin(ogen) or plasmin by contacting the mixture with a rigid amino...
|
|
|
7094378 |
Method and apparatus for inactivation of biological contaminants using photosensitizers
Methods and apparatuses for treating fluids to inactivate microorganisms which may be present therein, said fluid containing one or more components selected from the group consisting of protein,...
|
|
|
7041302 |
Therapeutic modulation of the tumor inflammatory response
The invention relates to compositions, kits, and methods for alleviating cancer (i.e., a tumor) in a human patient. The therapeutic modality effected by the invention involves inducing a type 1...
|
|
|
7015198 |
Materials for soft tissue augmentation and methods of making and using same
Materials for soft tissue augmentation in mammals are prepared by cross-linking blood plasma proteins, preferably with a zero-length cross-linking agent. The cross-linked blood plasma proteins can...
|
|
|
6831157 |
Process for the purification of serum albumin
Recombinantly produced serum albumin is purified in a series of steps, optionally by incubation with an anion-exchange adsorbent, followed by affinity chromatography employing a hydrophobic solid...
|
|
|
6830762 |
Autologous fibrin sealant and method for making the same
The present relates to an autologous bioadhesive sealant composition or fibrin glue prepared by a two-phase method, wherein all of the blood components for the bioadhesive sealant are derived from...
|
|
|
6783775 |
Serum-derived factor inducing cell differentiation and medical uses thereof
The present invention relates to a biologically active serum-derived composition of matter (SDF), having a low molecular weight, being electrically charged at acidic pH and having absorption at 280...
|
|
|
6770278 |
Methods of making and using immunoglobulin (Ig) compositions
The invention is directed to methods of using Ig compositions to prevent and/or treat humans, livestock and/or domesticated animals suffering from stress induced respiratory disorders. The Ig...
|
|
|
6709413 |
Platelet gel manufacturer for use in a closed corporeal circuit
The platelet gel manufacturer includes a platelet gel applicator, a controllable platelet receptacle, a controllable coagulant receptacle, and a controllable platelet gel receptacle. The...
|
|
|
6695805 |
Systems and methods for removing free and entrained contaminants in plasma
Systems and methods treat plasma carrying contaminants and leukocytes that are capable of entraining contaminants. The systems and methods separate leukocytes from the plasma by filtration, thereby...
|
|
|
6649072 |
Method for producing autologous platelet-rich plasma
A novel method for producing an autologous platelet rich blood composition is described. The resulting blood composition is useful in procedures for enhancing bone fusion, hemostasis, and repairing...
|
|
|
6610496 |
Prediction of growth performance and composition in animals, including cattle, from response to growth hormone releasing hormone
A method for predicting animal growth performance, which includes administering a suitable amount of growth hormone releasing hormone (GHRH) to an animal, observing levels of growth hormone (GH)...
|
|
|
6596318 |
Fibrin tissue adhesive formulation and process for its preparation
A solid formulation of a fibrin tissue adhesive for use in medical procedures is disclosed. The formulation is a mixture containing thrombin and fibrinogen with factor XIII in a pourable solid...
|
|
|
6596180 |
System and method for the production of autologous platelet gel
A centrifuge system for the formation of an autologous platelet gel wherein all of the blood components for the gel are derived from a patient to whom the gel is to be applied. First a platelet...
|
|
|
6589526 |
Enrichment of dendritic cells from blood
A method for the enrichment of dendritic cells from the peripheral blood of a mammal is described. Peripheral blood having mononuclear cells from a mammal is provided. The mononuclear cells are...
|
|
|
6579537 |
Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanine
A method of producing a pharmaceutical preparation comprising fibronectin and fibrinogen is disclosed. The method involves admixing into a starting solution of fibrinogen and fibronectin, in a...
|
|
|
6569465 |
Chemical alteration of mammal urine and mammal blood
A method for chemical modification of mammal urine and mammal blood is disclosed.
|
|
|
6569420 |
Human interferon-&egr : a type I interferon
The invention concerns a novel human interferon-ε, originally designated PRO655, and its variants and derivatives. The novel interferon is related to but distinct from members of the IFN-α family...
|
|
|
6544727 |
Methods and devices for the removal of psoralens from blood products
Methods and devices for the removal of psoralens and psoralen photoproducts from blood products are described. The methods include contacting a psoralen- and irradiation-treated blood product with...
|
|
|
6524622 |
Method of controlling the working time of a gypsum composition in the bone treatment
A method is designed to control the working time, setting time and the semi-solidification time of a gypsum composition in a bone restoration operation. The method involves a preparation of the...
|
|
|
6509147 |
Method for therapeutic immunmodulation of plasma
A process and set-up of therapeutic immunomodulation is provided for medicine. Many illnesses (i.e. Sepsis) are, among other things, characterized by a disruption of the immune system. In spite of...
|
|
|
6500427 |
One-component tissue adhesive and a process for the production thereof
A description is given of a one-component tissue adhesive containing, in aqueous solution, fibrinogen, F XIII, a thrombin inhibitor, prothrombin factors, calcium ions and, where appropriate, a...
|
|
|
6485753 |
Diagnostic marker for vascular endothelial injury
A method for diagnosing vascular endothelial injury, which comprises measuring the serotonin level in a plasma sample.
|
|
|
6479052 |
Spray delivery of cells
Provided is, among other things, a method of adhering cells to a target surface which is a tissue surface of a mammal or such a tissue surface coated with a biodegradable polymer sheet, comprising:...
|
|
|
6468733 |
Method of the inactivation of viruses by a solvent-detergent combination and nanofiltration
The invention concerns a method for elimination of viruses from a biological preparation wherein initially enveloped viruses are eliminated by a solvent-detergent step, then the solvent-detergents...
|
|
|
6440417 |
Antibodies to argatroban derivatives and their use in therapeutic and diagnostic treatments
Antibodies to a therapeutic agent and its derivatives and conjugates are disclosed, including antibodies to argatroban and its derivatives and conjugates. The antibodies are useful as reagents in...
|
|
|
6416717 |
Evacuated blood collection tube for rapid blood coagulation
Providing an evacuated blood collection tube for blood collection rapidly, whereby serum of high purity can be isolated in a rapid and simple manner with no occurrence of fibrin deposition. Beads...
|
|
|
6391295 |
Artificial bait
The present invention relates to an artificial bait for marine animals, comprising cell-free hemolymph of a horseshoe crab. The cell-free hemolymph of the horseshoe crab, which is the byproduct...
|
|
|
6368298 |
Preparing autologous fibrin glue
A method of preparing a solid-fibrin web is disclosed. The method includes drawing blood from a patient, separating plasma from the blood, contacting the plasma with a calcium-coagulation activator...
|
|
|
6358534 |
Immunotolerant prothrombin complex preparation
The invention relates to an immunotolerant prothrombin complex preparation, a method of producing this preparation, as well as the use of the preparation for producing a medicament,
|
|
|
6355246 |
Feline calicivirus isolated from cat urine and vaccines thereof
The present invention provides an isolated feline calicivirus and mutants thereof, which were isolated from the urine of a cat with lower urinary tract disorder. The present invention further...
|
|
|
6346277 |
Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X
The present invention relates to a process for the preparation of a product of blood coagulation factors II, VII, IX and X which is virtually free of virus, the process comprising heating an...
|
|
|
6340667 |
Reptilian-derived peptides for the treatment of microbial infections
The present invention provides compositions useful as antimicrobial agents which include reptilian hemoglobin, the α and β chains of hemoglobin free of heme, fragments of said proteins or...
|
|
|
6337314 |
Mammalian-derived peptides for the treatment of microbial infections
The present invention provides compositions useful as antimicrobial agents which include mammalian hemoglobin, the α and β chains of hemoglobin free of heme, fragments of the α and β chains...
|
|
|
6303152 |
Process for the production of substances that have been bactericidally treated and/or exhibit immune-modulatory activity, and the use thereof
A process is disclosed for the production of immune-genetically active suspensions of which the initial substances are fluids or tissues from the human or animal body. Autohemotherapy,...
|
|
|
6284285 |
Tissue repair promoting composition
A method for isolating tissue repair promoting substances from human or animal blood, which method comprises collecting the human or animal blood from a single human or animal individual in a first...
|
|
|
6262236 |
Fibrin sealant compositions and methods for utilizing same
The subject invention relates to fibrin sealants. More specifically, the subject invention relates to the use of a fibrin sealant wherein a composition comprising fibrin monomer or a composition...
|
|
|
6255278 |
Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens
A method for controlling immune reactions to a foreign tissue or a foreign cell in a recipient host mammal to enhance tolerance of the recipient host mammal towards a grafted foreign tissue or a...
|